Sutro Biopharma (STRO) Cash & Equivalents (QoQ) (2017 - 2025)
Sutro Biopharma (STRO) Cash & Equivalents (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.83% |
| Sep 30, 2025 | 2.97% |
| Jun 30, 2025 | -39.73% |
| Mar 31, 2025 | -44.18% |
| Dec 31, 2024 | 9.01% |
| Sep 30, 2024 | 92.29% |
| Jun 30, 2024 | 39.21% |
| Mar 31, 2024 | -5.85% |
| Dec 31, 2023 | -15.36% |
| Sep 30, 2023 | -65.19% |
| Jun 30, 2023 | 276.32% |
| Mar 31, 2023 | 32.20% |
| Dec 31, 2022 | -51.17% |
| Sep 30, 2022 | 22.33% |
| Jun 30, 2022 | 173.74% |
| Mar 31, 2022 | -4.97% |
| Dec 31, 2021 | -0.95% |
| Sep 30, 2021 | -45.55% |
| Jun 30, 2021 | 1.03% |
| Mar 31, 2021 | -72.92% |